NANDROLONE PHENYLPROPIONATE 1 ml/ 100 mg
Nandrolone Phenylpropionate USP29, BP2005,100 mg
Nandrolone Formula:C18H26O2(CAS-434-22-0,ATC-A14AB01 ;S01 XA11)
MolecularWeight (base):406.557 gm/mol
Active life: 10 days
Detection time: up to 8 months
Anabolic/Androgenic ratio: 37:125
Nandrolone Phenylpropionate is a steroid compound that is described chemically as 17(3- hydroxyestr-4-en-3-one 3- phenylpropionate. It occurs as a white to creamy-white crystalline powder with characteristic odour. Practical insoluble in water, soluble in alcohol.
DECA 100“ is fast acting Nandrolone which is an oil based solution of Nandrolone Phenylpropionate ester: Decanoate USP29, BP2005, which is designed forfast acting Nandrolone in reasonable concentration.
DECA 100® is available as a sterile solution of Nandrolone, a suitable-action anabolic agent,for only intramuscular injection.
Anabolic steroids are synthetic derivatives of testosterone. Certain clinical effects and adverse reactions demonstrate the androgenic properties of this class of drugs. No dissociation of androgenic and anabolic potency has been demonstrated clinically for any anabolic steroid although there is some suggestion from animal studies that such dissociation may be possible.
The actions of anabolic steroids are therefore similar to those of male sex hormones with the possibility of causing serious disturbances of growth and sexual development if given to young children. Anabolic steroids suppress the gonadotropic functions of the pituitary and may exert a direct effect upon the testes.
During exogenous administration of anabolic androgens, endogenous testosterone release is inhibited through inhibition of pituitary luteinizing hormone (LH). At large doses, spermatogenesis may be suppressed through feedbackinhibition of pituitary follicle-stimulation hormone (FSH).
Anabolic steroids increase low-density lipoproteins and decrease high-density lipoproteins.These changes revertto normal on discontinuation oftreatment.
INDICATIONS AND USAGE:
DECA 100® is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Surgically induced nephric patients have been reported to be less responsive.
DECA 100® is used alone or as an adjunct in the treatment of anemia secondary to bone marrow failure, breast cancer in postmenopausal women, non-small cell lung cancer, and postmenopausal osteoporosis.
1. Known or suspected carcinoma of the prostate orthe male breast.
2. Carcinoma of the breast in females with hypercalcemia (androgenic anabolic steroids may stimulate osteolytic bone resorption).
3. Pregnancy, because of possible masculinizationofthefemale fetus. Androgenic anabolic steroids are known to cause embryotoxicity, fetotoxicity, and masculinization of female animal offspring. DECA 100® is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, she should be apprised of the potential hazard to the fetus.
4. Nephrosis orthe nephrotic phase of nephritis.